GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Control Bionics Ltd (ASX:CBL) » Definitions » Interest Coverage

Control Bionics (ASX:CBL) Interest Coverage : 0 (At Loss) (As of Dec. 2024)


View and export this data going back to 2020. Start your Free Trial

What is Control Bionics Interest Coverage?

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income by its Interest Expense. Control Bionics's Operating Income for the six months ended in Dec. 2024 was A$-3.62 Mil. Control Bionics's Interest Expense for the six months ended in Dec. 2024 was A$-0.06 Mil. did not have earnings to cover the interest expense. The higher the ratio, the stronger the company's financial strength is.

The historical rank and industry rank for Control Bionics's Interest Coverage or its related term are showing as below:


ASX:CBL's Interest Coverage is not ranked *
in the Medical Devices & Instruments industry.
Industry Median: 17.2
* Ranked among companies with meaningful Interest Coverage only.

Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.


Control Bionics Interest Coverage Historical Data

The historical data trend for Control Bionics's Interest Coverage can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Note: For Interest Coverage, "No debt" indicates no long-term debt. An indication of "No Debt" does not necessarily mean that the company has no long-term debt obligations; it could be due to missing data in the quarterly or annual report. Use caution when interpreting this information.

* Premium members only.

Control Bionics Interest Coverage Chart

Control Bionics Annual Data
Trend Jun21 Jun22 Jun23 Jun24
Interest Coverage
- - - -

Control Bionics Semi-Annual Data
Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24
Interest Coverage Get a 7-Day Free Trial Premium Member Only - - - - -

Competitive Comparison of Control Bionics's Interest Coverage

For the Medical Devices subindustry, Control Bionics's Interest Coverage, along with its competitors' market caps and Interest Coverage data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Control Bionics's Interest Coverage Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Control Bionics's Interest Coverage distribution charts can be found below:

* The bar in red indicates where Control Bionics's Interest Coverage falls into.


;
;

Control Bionics Interest Coverage Calculation

Interest Coverage is a ratio that determines how easily a company can pay interest expenses on outstanding debt. It is calculated by dividing a company's Operating Income (EBIT) by its Interest Expense:

If Interest Expense is negative and Operating Income is positive, then

Interest Coverage=-1* Operating Income /Interest Expense

Else if Interest Expense is negative and Operating Income is negative, then

The company did not have earnings to cover the interest expense.

Else if Interest Expense is 0 and Long-Term Debt & Capital Lease Obligation is 0, then

The company had no debt (1).


Note: If both Interest Expense and Interest Income are empty, while Net Interest Income is negative, then use Net Interest Income as Interest Expense.

Control Bionics's Interest Coverage for the fiscal year that ended in Jun. 2024 is calculated as

Here, for the fiscal year that ended in Jun. 2024, Control Bionics's Interest Expense was A$-0.06 Mil. Its Operating Income was A$-7.09 Mil. And its Long-Term Debt & Capital Lease Obligation was A$0.34 Mil.

Control Bionics did not have earnings to cover the interest expense.

Control Bionics's Interest Coverage for the quarter that ended in Dec. 2024 is calculated as

Here, for the six months ended in Dec. 2024, Control Bionics's Interest Expense was A$-0.06 Mil. Its Operating Income was A$-3.62 Mil. And its Long-Term Debt & Capital Lease Obligation was A$0.24 Mil.

Control Bionics did not have earnings to cover the interest expense.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

The higher the ratio, the stronger the company's Financial Strength is.


Control Bionics  (ASX:CBL) Interest Coverage Explanation

Ben Graham requires that a company has a minimum interest coverage of 5 with the companies he invested. If the interest coverage is less than 2, the company is burdened by debt. Any business slow or recession may drag the company into a situation where it cannot pay the interest on its debt.

Interest Coverage is an important factor when GuruFocus ranks a company's overage Financial Strength .


Control Bionics Interest Coverage Related Terms

Thank you for viewing the detailed overview of Control Bionics's Interest Coverage provided by GuruFocus.com. Please click on the following links to see related term pages.


Control Bionics Business Description

Traded in Other Exchanges
N/A
Address
11-13 Pearson Street, Level 4, Cremorne, VIC, AUS, 3121
Control Bionics Ltd is engaged in the healthcare device business. It is involved in developing, commercializing, and selling assistive communications technology systems within the disability sector. Its core systems include NeuroNode Trilogy and NeuroNode3. These systems allow people with speech and movement difficulties to control a computer for speech generation, electronic communications, entertainment, and external control of other devices. Geographically it derives a majority of revenue from North America and has its presence in Australia as well.